Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth - MSN

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ... Read More

Do You Believe in the Growth Trajectory of Boston Scientific Corporation (BSX)?

Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first ... Read More

Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts

Boston Scientific BSX is gaining market share across all segments. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy ... Read More

Boston Scientific’s Farapulse Poised for Growth on Positive Physician Sentiment and Anticipated Reimbursement Incentives - Markets Insider

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target of $72.00. Larry Biegelsen has given his Buy rating to ... Read More

Boston Scientific Corporation (BSX) Q2 2024 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q2 2024 Earnings Conference Call July 24, 2024 8:00 AM ETCompany ParticipantsJon Monson - SVP, IRMichael F. Read More

Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth - Yahoo Finance

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ... Read More

Boston Scientific Corporation (BSX) Q2 2023 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q2 2023 Earnings Conference Call July 27, ... representing 15% to 17% growth versus 2022, ... And the timing of the FARAPULSE launch here in the U.S. Read More

Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth

News Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth Published on September 30, 2024 at 4:50 am by Laiba Immad in News ... Read More

Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth - Yahoo Finance

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against ... Read More